Clinical efficacy of vitrectomy combined with preoperative intraocular injection of compacept in the treatment of proliferative diabetic retinopathy
Objective:To explore and analyze the clinical effect of vitrectomy combined with preoperative intraocular injection of Compaxil on proliferative diabetic retinopathy(DR).Methods:Eighty patients(91 eyes)with proliferative DR admitted to the Department of Ophthalmology of Changzhou First People's Hospital from January 2022 to De-cember 2023 were selected.According to the random number table method,they were divided into two groups,40 cases in each group.The control group(46 eyes)only underwent vitrectomy,while the observation group(45 eyes)underwent vitrectomy combined with Compaxip.Before operation and one month after operation,the eye indexes,intraoperative and postoperative complications were compared between the two groups.Results:One month after op-eration,cRMT was lower and BCVA was higher in both groups,while cRMT in observation group was lower and BCVA was higher than that in control group,P＜0.05.The incidence of complications between the two groups was compared,P＞0.05.Conclusion:Vitrectomy combined with preoperative intraocular injection of Compaxil can obvi-ously improve the vision of patients with proliferative DR and reduce macular edema,which is safe and effective.
国家科技期刊平台
NSTL
万方数据
